Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis

Christof Straub, Jason P. Burnham, A. Clinton White, Konrad Pazdrak, Cesar Sanchez, Luis Carlos Watanabe, Alexander Kurosky, Martín Montes

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We used comparative proteomics to analyze eosinophils from a patient with hypereosinophilia due to fascioliasis. Using 2-dimensional electrophoresis and mass spectrometry, we demonstrated that the eosinophil proteome was significantly altered compared to those of healthy controls.

Original languageEnglish (US)
Pages (from-to)1999-2002
Number of pages4
JournalClinical and Vaccine Immunology
Volume18
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Fascioliasis
Proteome
Electrophoresis
Eosinophils
Mass spectrometry
Proteomics
Mass Spectrometry

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Straub, C., Burnham, J. P., White, A. C., Pazdrak, K., Sanchez, C., Watanabe, L. C., ... Montes, M. (2011). Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis. Clinical and Vaccine Immunology, 18(11), 1999-2002. https://doi.org/10.1128/CVI.05373-11

Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis. / Straub, Christof; Burnham, Jason P.; White, A. Clinton; Pazdrak, Konrad; Sanchez, Cesar; Watanabe, Luis Carlos; Kurosky, Alexander; Montes, Martín.

In: Clinical and Vaccine Immunology, Vol. 18, No. 11, 11.2011, p. 1999-2002.

Research output: Contribution to journalArticle

Straub, C, Burnham, JP, White, AC, Pazdrak, K, Sanchez, C, Watanabe, LC, Kurosky, A & Montes, M 2011, 'Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis', Clinical and Vaccine Immunology, vol. 18, no. 11, pp. 1999-2002. https://doi.org/10.1128/CVI.05373-11
Straub, Christof ; Burnham, Jason P. ; White, A. Clinton ; Pazdrak, Konrad ; Sanchez, Cesar ; Watanabe, Luis Carlos ; Kurosky, Alexander ; Montes, Martín. / Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis. In: Clinical and Vaccine Immunology. 2011 ; Vol. 18, No. 11. pp. 1999-2002.
@article{7012832546404250a1d1adfe1f3cb129,
title = "Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis",
abstract = "We used comparative proteomics to analyze eosinophils from a patient with hypereosinophilia due to fascioliasis. Using 2-dimensional electrophoresis and mass spectrometry, we demonstrated that the eosinophil proteome was significantly altered compared to those of healthy controls.",
author = "Christof Straub and Burnham, {Jason P.} and White, {A. Clinton} and Konrad Pazdrak and Cesar Sanchez and Watanabe, {Luis Carlos} and Alexander Kurosky and Mart{\'i}n Montes",
year = "2011",
month = "11",
doi = "10.1128/CVI.05373-11",
language = "English (US)",
volume = "18",
pages = "1999--2002",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis

AU - Straub, Christof

AU - Burnham, Jason P.

AU - White, A. Clinton

AU - Pazdrak, Konrad

AU - Sanchez, Cesar

AU - Watanabe, Luis Carlos

AU - Kurosky, Alexander

AU - Montes, Martín

PY - 2011/11

Y1 - 2011/11

N2 - We used comparative proteomics to analyze eosinophils from a patient with hypereosinophilia due to fascioliasis. Using 2-dimensional electrophoresis and mass spectrometry, we demonstrated that the eosinophil proteome was significantly altered compared to those of healthy controls.

AB - We used comparative proteomics to analyze eosinophils from a patient with hypereosinophilia due to fascioliasis. Using 2-dimensional electrophoresis and mass spectrometry, we demonstrated that the eosinophil proteome was significantly altered compared to those of healthy controls.

UR - http://www.scopus.com/inward/record.url?scp=80455135098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455135098&partnerID=8YFLogxK

U2 - 10.1128/CVI.05373-11

DO - 10.1128/CVI.05373-11

M3 - Article

VL - 18

SP - 1999

EP - 2002

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 11

ER -